MBNL2 Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-87784
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Format
BSA Free
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the N-terminal region of human MBNL2. Peptide sequence: CRQFQRGTCSRSDEECKFAHPPKSCQVENGRVIACFDSLKGRCSRENCKY The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Description
Novus Biologicals Rabbit MBNL2 Antibody - BSA Free (NBP2-87784) is a polyclonal antibody validated for use in WB. All Novus Biologicals antibodies are covered by our 100% guarantee.
Scientific Data Images for MBNL2 Antibody - BSA Free
Western Blot: MBNL2 Antibody [NBP2-87784]
Western Blot: MBNL2 Antibody [NBP2-87784] - Host: Rabbit. Target Name: MBNL2. Sample Tissue: Liver Tumor lysates. Antibody Dilution: 1ug/mlApplications for MBNL2 Antibody - BSA Free
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Format
BSA Free
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: MBNL2
Alternate Names
DKFZp781H1296, MBLL39Muscleblind-like protein 1, MBLLMGC120628, MGC120625, MGC120626, MLP1, muscleblind-like 2 (Drosophila), muscleblind-like protein 2, Muscleblind-like protein-like, Muscleblind-like protein-like 39, PRO2032
Gene Symbol
MBNL2
Additional MBNL2 Products
Product Specific Notices for MBNL2 Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...